Summary & Overview
HCPCS J0898: Argatroban Injection, 1 mg (Non-ESRD Use)
HCPCS Level II code J0898 denotes argatroban (auromedics) injection, billed per 1 mg for non-ESRD use. This injectable direct thrombin inhibitor is used in clinical situations requiring anticoagulation when heparin is contraindicated, and clear coding distinguishes it from other argatroban products such as J0883. Nationally, precise HCPCS reporting matters for drug utilization tracking, payer coverage determinations, and facility billing of infused anticoagulants.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how J0898 is described in claims, the typical sites of service for administration, common modifiers encountered in billing workflows, and where to expect documentation and coding distinctions that affect reimbursement and audit review. The publication also outlines benchmarks and policy considerations relevant to infused specialty drugs billed via HCPCS Level II codes, clarifies clinical context for non-ESRD argatroban use, and identifies gaps where input data was not provided. This summary is intended for a national audience of coding professionals, revenue cycle staff, and clinician-administrators seeking concise guidance on the clinical and billing identity of HCPCS Level II code J0898.
Billing Code Overview
HCPCS Level II code J0898 represents the medication argatroban (auromedics) supplied as an injection and billed per milligram. The descriptor specifies that J0898 is not therapeutically equivalent to J0883 and is reported in increments of 1 mg for non-ESRD (end-stage renal disease) use.
Service Type: Injectable anticoagulant therapy provided as a parenteral medication.
Typical Site of Service: Hospital inpatient and outpatient settings, observation units, and ambulatory infusion centers where intravenous anticoagulant administration and monitoring occur.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for treatment of heparin-induced thrombocytopenia (HIT) or suspected HIT with a need for therapeutic anticoagulation without use of heparin. The patient may have an acute thrombotic event (e.g., deep vein thrombosis or pulmonary embolism) or be undergoing percutaneous coronary intervention (PCI) with contraindication to heparin. Argatroban is administered as an intravenous infusion after an initial bolus or dosing protocol is initiated by the physician. The clinical workflow includes baseline coagulation studies (activated partial thromboplastin time, aPTT), vascular access placement (peripheral or central line), initiation of argatroban per hospital protocol, serial aPTT monitoring to titrate infusion, documentation of dose and lot number in the medication administration record, and coordination with pharmacy for billing of the drug using the HCPCS Level II code J0898 (argatroban, 1 mg). Typical sites of service include inpatient hospital wards, intensive care units, and cardiac catheterization laboratories. Common scenarios include transition from heparin-based therapy, management of HIT during acute thrombotic events, and anticoagulation during PCI in patients with heparin allergy or HIT history.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies |
22 | Increased Procedural Service | Use when a procedure associated with argatroban administration requires substantially greater complexity or time (e.g., complicated vascular access placement) |
23 | Unusual Anesthesia | Use if general anesthesia is required for a concurrent procedure during which argatroban is administered |
52 | Reduced Services | Use when the planned service is partially reduced or not completed but still billed |
53 | Discontinued Procedure | Use when a procedure is started but discontinued for clinical reasons prior to completion |
62 | Two Surgeons | Use when two surgeons are required for a concurrent invasive procedure where argatroban is administered |
78 | Return to OR for Related Procedure Following Initial Procedure | Use when the patient returns to the operating room for a related complication and argatroban is administered during the subsequent procedure |
80 | Assistant Surgeon | Use when an assistant surgeon participates in the procedure during which argatroban is administered |
82 | Assistant Surgeon (When a Qualified Resident Surgeon Not Available) | Use when an assistant surgeon is required and no qualified resident is available |
AS | Physician Assistant, Nurse Practitioner, or Clinical Nurse Specialist services for Medicare | Use when a PA/NP/CNS furnishes services related to argatroban administration under applicable rules |
JW | Drug amount discarded/not administered | Use when a portion of a single-use vial of argatroban is discarded and documentation supports wastage billing conventions per payer policies |
QK | Medical Direction of Two, Three, or Four Certified Registered Nurse Anesthetists (CRNAs) by an Anesthesiologist | Use when anesthesia direction is reported for a procedure where argatroban was administered during anesthesia care |
QX | CRNA Service: CRNA with Medical Direction by a Physician | Use when CRNA furnishes anesthesia services with physician direction during a procedure involving argatroban |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
2084P0800X | Cardiovascular Surgeon | Manages operative procedures that may require non-heparin anticoagulation |
207RC0000X | Interventional Cardiologist | Performs PCI and catheter-based procedures where argatroban is used as alternative anticoagulant |
207L00000X | Hematology | Manages HIT diagnosis and anticoagulation decisions involving argatroban |
207K00000X | Critical Care Medicine | Oversees anticoagulation in critically ill patients receiving argatroban in ICU settings |
363LA2200X | Hospitalist | Coordinates inpatient medication management and monitoring for argatroban |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
D75.82 | Heparin-induced thrombocytopenia (HIT) | Primary indication for use of argatroban as an alternative anticoagulant when heparin is contraindicated |
I82.40 | Acute embolism and thrombosis of unspecified deep veins of lower extremity | An acute venous thromboembolism requiring anticoagulation where argatroban may be used if HIT is present |
I26.9 | Pulmonary embolism without acute cor pulmonale | Acute PE in a patient with HIT or heparin allergy necessitating non-heparin anticoagulation |
I21.3 | ST elevation (STEMI) myocardial infarction of other anterior wall | Acute coronary syndrome where PCI may require argatroban when heparin is contraindicated |
T45.515A | Adverse effect of anticoagulants, initial encounter | Complication related to anticoagulant therapy leading to switch to argatroban in some cases |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
36415 | Collection of venous blood by venipuncture | Obtaining baseline and monitoring coagulation studies (aPTT) before and during argatroban infusion |
36556 | Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older | Central venous access placement commonly used for continuous argatroban infusion in acute care settings |
92928 | Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch — performed with anticoagulation alternative to heparin when indicated | Argatroban may be used during PCI when heparin is contraindicated or in HIT history |
99223 | Initial hospital care, typically 70 minutes or more, for complex or critically ill patient | Hospital admission evaluation for a patient starting therapeutic argatroban infusion for HIT or acute thrombosis |
85025 | Blood count; automated differential WBC count | Routine laboratory monitoring in patients receiving argatroban, especially platelet count surveillance in suspected HIT |